Skip to content

Clinical Study on the Improvement of Chronic Obstructive Pulmonary Disease Complications and Malnutrition with Structured Lipids

Clinical Study on the Improvement of Chronic Obstructive Pulmonary Disease Complications and Malnutrition with Structured Lipids

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500100540
Enrollment
Unknown
Registered
2025-04-10
Start date
2024-12-03
Completion date
Unknown
Last updated
2025-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

Group A: Experimental Group (MLCT):An additional daily supplement of 25g of medium- and long-chain triglycerides (MLCT), outside of regular meals, for a duration of 8 weeks.
Group B: Control Group (MCT+LCT):An additional daily supplement of 25g of medium-chain triglycerides (MCT) and long-chain triglycerides (LCT) mixed oil, outside of regular meals, for a duration of 8 w
Group C: Blank Control Group:No intervention.

Sponsors

The First Affiliated Hospital of Gannan Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients clinically diagnosed with Chronic Obstructive Pulmonary Disease (COPD), including stage II (moderate) and stage III (severe) patients (classified according to the Global Initiative for Chronic Obstructive Lung Disease, GOLD, and the COPD Diagnosis and Treatment Guidelines); 2. Clear signs of malnutrition, with a Body Mass Index (BMI) <= 17.5 kg/m² and physical wasting; 3. Age between 18 and 80 years, regardless of gender (according to data from the COPD monitoring survey of Chinese residents, the COPD prevalence in individuals over 40 years old in China is 13.6%, with 19.0% in men and 8.1% in women, rapidly increasing with age); 4. Good dietary status, with no history of binge eating, compensatory eating behavior, extreme dieting, or alcohol abuse; 5. The subject or their guardian has signed an informed consent form; 6. The subject has completed a written informed consent form and agrees to cooperate with the study throughout the entire trial period.

Exclusion criteria

Exclusion criteria: 1. Abuse of narcotics or psychoactive drugs within the past 6 months; 2. Pregnant or breastfeeding women, or those planning to become pregnant within the next 6 months; 3. Poor patient compliance and low likelihood of follow-up; 4. Severe liver dysfunction; 5. Expected survival time less than 6 months.

Design outcomes

Primary

MeasureTime frame
Pulmonary function;6-minute walk test;BMI, body fat, muscle mass;

Secondary

MeasureTime frame
Complete blood count;Blood lipids;Blood glucose;Liver Function tests;Renal Function tests;

Countries

China

Contacts

Public ContactJianrong Zhou

The First Affiliated Hospital of Gannan Medical University

949423757@qq.com+86 139 7014 8762

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026